Announced details
Regenerative medicine, trauma and disaster medicine, urological trauma and reconstructive medicine, urethral injuries and urethral stricture, and ulcers and inflammation of the oral mucosa
Shinchi Yusuke (新地祐介) had previously cooperated with ART's research and development activities, and ART invited him to serve as a special advisor. ART is a consolidated subsidiary of the Company.
Lecturer in the Department of Urology at National Defense Medical College. Shinchi Yusuke (新地祐介) has clinical experience in urological trauma and reconstructive medicine and serves as vice chair of the Trauma, Emergency Medicine and Reconstruction Subcommittee of the Japanese Urological Association's Specialist Fields Committee.
Japanese Urological Association General Meeting Award (104th, 109th and 111th meetings), Urological Reconstruction and Regeneration Research Group Award (12th and 14th meetings), 18th GURS-Masterclass Best Poster Prize, board-certified and supervising specialist of the Japanese Urological Association, and certified physician of the Japanese Society for Regenerative Medicine
Japanese Urological Association, Urological Reconstruction and Regeneration Research Group, GURS-Masterclass, and Japanese Society for Regenerative Medicine
No impact on the results for the current fiscal year was stated
The company does not address Contract Value / Offering price.
The Company's medium-term management plan materials released on 13 February 2026, and the 25th Annual Meeting of the Japanese Society for Regenerative Medicine
| Item | Details |
|---|---|
| Names of Products / Services Covered | ARTT01, EV-based photocurable gel hemostatic agent, ARTU01, UREVEXⓇ, ARTO01, UREVEXⓇ Oral Solution (tentative name) |
| Counterparty | Shinchi Yusuke (新地祐介) / National Defense Medical College |
| Counterparty overview | Lecturer in the Department of Urology at National Defense Medical College. Shinchi Yusuke (新地祐介) has clinical experience in urological trauma and reconstructive medicine and serves as vice chair of the Trauma, Emergency Medicine and Reconstruction Subcommittee of the Japanese Urological Association's Specialist Fields Committee. |
| Relationship with the Company | Shinchi Yusuke (新地祐介) had previously cooperated with ART's research and development activities, and ART invited him to serve as a special advisor. ART is a consolidated subsidiary of the Company. |
| Launch date | 23 March 2026 (appointment date; actual) |
| Applicable area | Regenerative medicine, trauma and disaster medicine, urological trauma and reconstructive medicine, urethral injuries and urethral stricture, and ulcers and inflammation of the oral mucosa |
| Award/certification name | Japanese Urological Association General Meeting Award (104th, 109th and 111th meetings), Urological Reconstruction and Regeneration Research Group Award (12th and 14th meetings), 18th GURS-Masterclass Best Poster Prize, board-certified and supervising specialist of the Japanese Urological Association, and certified physician of the Japanese Society for Regenerative Medicine |
| Awarding / certifying body | Japanese Urological Association, Urological Reconstruction and Regeneration Research Group, GURS-Masterclass, and Japanese Society for Regenerative Medicine |
| Impact on Business Performance | No impact on the results for the current fiscal year was stated |
| Source | The Company's medium-term management plan materials released on 13 February 2026, and the 25th Annual Meeting of the Japanese Society for Regenerative Medicine |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further accelerate research and development in the fields of trauma and reconstructive medicine using extracellular vesicles (EVs), strengthen the business foundation through academic advice, advice on research and development strategy, and support for translating research into clinical applications.